1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Rare Neurological Disease Treatment Market– By Indication
1.3.2 Global Rare Neurological Disease Treatment Market– By Drug Type
1.3.3 Global Rare Neurological Disease Treatment Market– By Distribution Channel
1.3.4 Global Rare Neurological Disease Treatment Market – By Mode of Administration
1.3.5 Global Rare Neurological Disease Treatment Market– By Geography
2. Rare Neurological Disease Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Rare Neurological Disease Treatment– Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa– PEST Analysis
4.2.5 South and Central America – PEST Analysis
5. Rare Neurological Disease Treatment– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Rare Neurological Diseases
5.1.2 Favourable Pipeline Drugs and Robust Research Activities for the Treatment of Rare Neurological Diseases
5.2 Key Market Restraints
5.2.1 High Treatment Cost for Rare Neurological Diseases
5.3 Key Market Opportunities
5.3.1 Increasing Awareness of Rare Neurological Diseases Coupled with Developing Healthcare Infrastructure
5.4 Future Trends
5.4.1 Artificial Intelligence for the Treatment of Rare Neurological Diseases
5.5 Impact Analysis
6. Rare Neurological Disease Treatment Market– Global Analysis
6.1 Global Rare Neurological Disease Treatment Market Revenue Forecast And Analysis
6.2 Global Rare Neurological Disease Treatment Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Rare Neurological Disease Treatment Market Analysis – By Indication
7.1 Overview
7.2 Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)
7.3 Narcolepsy
7.3.1 Overview
7.3.2 Narcolepsy: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Amyotrophic Lateral Sclerosis
7.4.1 Overview
7.4.2 Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Alzheimer’s Disease
7.5.1 Overview
7.5.2 Alzheimer’s Disease: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Multiple Sclerosis
7.6.1 Overview
7.6.2 Multiple Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.7 Spinal Muscular Atrophy (SMA)
7.7.1 Overview
7.7.2 Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Duchenne Muscular Dystrophy
7.8.1 Overview
7.8.2 Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Other Indications
7.9.1 Overview
7.9.2 Other Indications: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8. Rare Neurological Disease Treatment Market Analysis – By Drug Type
8.1 Overview
8.2 Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027, (%)
8.3 Organic Compounds
8.3.1 Overview
8.3.2 Organic Compounds: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Biologics
8.4.1 Overview
8.4.2 Biologics: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9. Rare Neurological Disease Treatment Market Analysis – By Distribution Channel
9.1 Overview
9.2 Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospital Pharmacies
9.4.1 Overview
9.4.2 Hospital Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Retail Pharmacies
9.5.1 Overview
9.5.2 Retail Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
10. Rare Neurological Disease Treatment Market Analysis – By Mode of Administration
10.1 Overview
10.2 Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)
10.3 Oral
10.3.1 Overview
10.3.2 Oral: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Inject able
10.4.1 Overview
10.4.2 Inject able: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
11. Rare Neurological Disease Treatment Market – Geographic Analysis
11.1 North America: Rare Neurological Disease Treatment Market
11.1.1 Overview
11.1.2 North America: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.4 North America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.5 North America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.6 North America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.1.7 North America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.1.8 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.8.3 US: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.8.4 US: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.8.5 US: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.1.9 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.9.3 Canada: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.9.4 Canada: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.9.5 Canada: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.1.10 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.1.10.3 Mexico: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.1.11 Mexico: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.1.11.1 Mexico: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2 Europe: Rare Neurological Disease Treatment Market
11.2.1 Overview
11.2.2 Europe: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.4 Europe: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.5 Europe: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.6 Europe: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.7 Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.2.8 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.8.3 Germany: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.8.4 Germany: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.8.5 Germany: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.8.6 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.7 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.8 United Kingdom: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.8.9 United Kingdom: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.8.10 United Kingdom: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.8.11 United Kingdom: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.9 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.1 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.2 France: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.9.3 France: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.9.4 France: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.9.5 France: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.10 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.1 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.2 Spain: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.10.3 Spain: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.10.4 Spain: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.10.5 Spain: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2.11 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Italy: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.2.11.3 Italy: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.2.11.4 Italy: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.2.11.5 Italy: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3 Asia Pacific: Rare Neurological Disease Treatment Market
11.3.1 Overview
11.3.2 Asia Pacific: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.4 Asia Pacific: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.5 Asia Pacific: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.6 Asia Pacific: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.7 Asia Pacific: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.3.8 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.8.3 China: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.8.4 China: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.8.5 China: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.9 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.9.3 Japan: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.9.4 Japan: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.9.5 Japan: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.10 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.10.3 India: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.10.4 India: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.10.5 India: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.11 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.11.3 South Korea: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.11.4 South Korea: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.11.5 South Korea: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3.12 Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.3.13 Australia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.3.13.1 Australia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.3.13.2 Australia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.3.13.3 Australia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.4 Middle East & Africa: Rare Neurological Disease Treatment Market
11.4.1 Overview
11.4.2 Middle East & Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East & Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.4 Middle East & Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.5 Middle East & Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.6 Middle East & Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.4.7 Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country – 2019 & 2027, (%)
11.4.8 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.8.3 Saudi Arabia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.8.4 Saudi Arabia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.8.5 Saudi Arabia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.4.9 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.9.3 UAE: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.9.4 UAE: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.9.5 UAE: Rare Neurological Disease Treatment Market, by Distribution Channel , 2018–2027 (USD Million)
11.4.10 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
11.4.10.1 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.4.10.3 South Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.4.10.4 South Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.4.10.5 South Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.5 South and Central America: Rare Neurological Disease Treatment Market
11.5.1 Overview
11.5.2 South and Central America: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
11.5.3 South and Central America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.5.4 South and Central America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.5.5 South and Central America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.5.6 South and Central America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.5.7 South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
11.5.8 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.5.8.3 Brazil: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.5.8.4 Brazil: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.5.8.5 Brazil: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.5.9 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
11.5.9.3 Argentina: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
11.5.9.4 Argentina: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
11.5.9.5 Argentina: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Rare Neurological Disease Treatment Market –Industry Landscape
13.1 Overview
13.2 Growth Strategies In The Rare Neurological Disease Treatment Market, 2017-2020
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Allergan Plc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bayer AG
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 GlaxoSmithKline plc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Johnson & Johnson Services, Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Merck & Co., Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Novartis AG
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Sanofi
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Teva Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Takeda Pharmaceutical Company Limited
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About
15.2 Glossary of Terms